JPH08510717A - 子宮血液潅流向上薬製造へのシクロオキシゲナーゼ阻害薬の使用 - Google Patents
子宮血液潅流向上薬製造へのシクロオキシゲナーゼ阻害薬の使用Info
- Publication number
- JPH08510717A JPH08510717A JP6515780A JP51578094A JPH08510717A JP H08510717 A JPH08510717 A JP H08510717A JP 6515780 A JP6515780 A JP 6515780A JP 51578094 A JP51578094 A JP 51578094A JP H08510717 A JPH08510717 A JP H08510717A
- Authority
- JP
- Japan
- Prior art keywords
- uterus
- aspirin
- mammal
- perfusion
- cyclooxygenase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Semiconductor Lasers (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.哺乳類の子宮を流れる血液の潅流を向上させるための薬剤製造へのシクロオ キシゲナーゼ阻害薬の使用。 2.哺乳類の子宮における胎芽移植を増強する薬剤の製造へのシクロオキシゲナ ーゼ阻害薬の使用。 3.哺乳類の子宮を流れる血液の潅流障害の予防薬の製造へのシクロオキシゲナ ーゼ阻害薬の使用。 4.前記シクロオキシゲナーゼ阻害薬は非ステロイド系抗炎症薬である、請求項 1乃至3の何れかに記載の使用。 5.前記非ステロイド系抗炎症薬がアスピリン、イブプロフェン、インドメタシ ンまたはナプロキセンである、請求項1乃至4の何れかに記載の使用。 6.対象となる前記哺乳類はヒトである、請求項1乃至5の何れかに記載の使用 。 7.前記シクロオキシゲナーゼ阻害薬を着床前2〜20日間投与する、請求項1乃 至6の何れかに記載の使用。 8.同時使用、分別使用または順次使用に適した形態で複合製剤として受胎を助 ける1種類以上のホルモンと併用するシクロオキシゲナーゼ阻害薬から成る医薬 品。 9.受胎を助ける1種類以上のホルモンと併用するシクロオキシゲナーゼ阻害薬 を含む組成物。 10.健康な哺乳類の子宮を流れる血液の潅流を向上させる方法であって、当該哺 乳類にシクロオキシゲナーゼ阻害薬を投与してなる方法。 11.健康な哺乳類の子宮内膜に胎芽を着床させる方法であって、着床前に当該哺 乳類にシクロオキシゲナーゼ阻害薬を投与してなる方法。 12.哺乳類の子宮を流れる血液の潅流が損なわれるのを予防する方法であって、 当該哺乳類にシクロオキシゲナーゼ阻害薬を投与してなる方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9227123.8 | 1992-12-30 | ||
GB929227123A GB9227123D0 (en) | 1992-12-30 | 1992-12-30 | Method |
PCT/GB1993/002657 WO1994015613A1 (en) | 1992-12-30 | 1993-12-24 | Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08510717A true JPH08510717A (ja) | 1996-11-12 |
JP3881690B2 JP3881690B2 (ja) | 2007-02-14 |
Family
ID=10727336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51578094A Expired - Fee Related JP3881690B2 (ja) | 1992-12-30 | 1993-12-24 | 子宮血液潅流向上薬製造へのシクロオキシゲナーゼ阻害薬の使用 |
Country Status (13)
Country | Link |
---|---|
US (2) | US5760024A (ja) |
EP (1) | EP0691847B1 (ja) |
JP (1) | JP3881690B2 (ja) |
AT (1) | ATE197545T1 (ja) |
AU (1) | AU683035B2 (ja) |
CA (1) | CA2151476C (ja) |
DE (1) | DE69329687T2 (ja) |
DK (1) | DK0691847T3 (ja) |
ES (1) | ES2151922T3 (ja) |
GB (1) | GB9227123D0 (ja) |
GR (1) | GR3035358T3 (ja) |
PT (1) | PT691847E (ja) |
WO (1) | WO1994015613A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9227123D0 (en) * | 1992-12-30 | 1993-02-24 | Applied Research Systems | Method |
EP1123687A3 (en) * | 2000-02-10 | 2004-02-04 | Aloka Co., Ltd. | Ultrasonic diagnostic apparatus |
US6695766B2 (en) | 2002-04-26 | 2004-02-24 | Olympia Womens Health | Magnetic embryo transfer |
EP1670902A4 (en) * | 2003-09-08 | 2008-05-07 | Univ Texas | METHOD AND COMPOSITION FOR ENHANCING IN VITRO EMBRYONIC DEVELOPMENT BY ENRICHING A CULTURE MEDIUM COMPRISING PROSTAGLANDIN OR PROSTAGLANDIN ANALOGUE |
AU2005257839A1 (en) | 2004-05-17 | 2006-01-05 | The General Hospital Corporation | Methods and compositions for producing germ cells from bone marrow derived germline stem cells |
US7705197B2 (en) * | 2005-01-19 | 2010-04-27 | University Of Tennessee Research Foundation | Embryo development and survival |
US7615585B2 (en) * | 2007-04-19 | 2009-11-10 | Troy Corporation | Degassing compositions for curable coatings |
WO2012142500A2 (en) | 2011-04-14 | 2012-10-18 | The General Hospital Corporation | Compositions and methods for autologous germline mitochondrial energy transfer |
EA201490050A1 (ru) | 2011-06-29 | 2014-07-30 | Зе Дженерэл Хоспитэл Корпорейшн | Композиции и способы повышения биоэнергетического состояния женских зародышевых клеток |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO91014B1 (ro) * | 1984-12-08 | 1987-02-28 | Raisa Motocescu | Gel hormonal si antiprostaglandinic |
KR920700648A (ko) * | 1989-05-05 | 1992-08-10 | 오닐 크리스토퍼 | 가임성 향상 |
GB9227123D0 (en) * | 1992-12-30 | 1993-02-24 | Applied Research Systems | Method |
-
1992
- 1992-12-30 GB GB929227123A patent/GB9227123D0/en active Pending
-
1993
- 1993-12-24 ES ES94902962T patent/ES2151922T3/es not_active Expired - Lifetime
- 1993-12-24 AU AU57113/94A patent/AU683035B2/en not_active Ceased
- 1993-12-24 EP EP94902962A patent/EP0691847B1/en not_active Expired - Lifetime
- 1993-12-24 JP JP51578094A patent/JP3881690B2/ja not_active Expired - Fee Related
- 1993-12-24 CA CA002151476A patent/CA2151476C/en not_active Expired - Fee Related
- 1993-12-24 DE DE69329687T patent/DE69329687T2/de not_active Expired - Fee Related
- 1993-12-24 PT PT94902962T patent/PT691847E/pt unknown
- 1993-12-24 AT AT94902962T patent/ATE197545T1/de not_active IP Right Cessation
- 1993-12-24 DK DK94902962T patent/DK0691847T3/da active
- 1993-12-24 WO PCT/GB1993/002657 patent/WO1994015613A1/en active IP Right Grant
- 1993-12-24 US US08/464,785 patent/US5760024A/en not_active Expired - Fee Related
-
1997
- 1997-12-05 US US08/985,590 patent/US6100249A/en not_active Expired - Fee Related
-
2001
- 2001-02-02 GR GR20010400183T patent/GR3035358T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69329687T2 (de) | 2001-05-10 |
JP3881690B2 (ja) | 2007-02-14 |
US6100249A (en) | 2000-08-08 |
GB9227123D0 (en) | 1993-02-24 |
CA2151476A1 (en) | 1994-07-25 |
ES2151922T3 (es) | 2001-01-16 |
DE69329687D1 (de) | 2000-12-21 |
EP0691847B1 (en) | 2000-11-15 |
AU5711394A (en) | 1994-08-15 |
GR3035358T3 (en) | 2001-05-31 |
ATE197545T1 (de) | 2000-12-15 |
EP0691847A1 (en) | 1996-01-17 |
CA2151476C (en) | 2005-05-24 |
US5760024A (en) | 1998-06-02 |
DK0691847T3 (da) | 2000-12-11 |
PT691847E (pt) | 2001-02-28 |
AU683035B2 (en) | 1997-10-30 |
WO1994015613A1 (en) | 1994-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wada et al. | Pregnancy: the benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception | |
Thatcher et al. | Strategies for improving fertility in the modern dairy cow | |
Sterzik et al. | In vitro fertilization: the degree of endometrial insufficiency varies with the type of ovarian stimulation | |
JP7184935B2 (ja) | 生殖補助医療を受けている女性における着床及び妊娠のための黄体期のオキシトシン受容体アンタゴニスト療法 | |
JP6124411B2 (ja) | プロゲステロンを含むモノリシック膣内リングならびにそれらの製造方法および使用 | |
Guilbault et al. | Influence of a physiological infusion of prostaglandin F2α into postpartum cows with partially suppressed endogenous production of prostaglandins. 1. Uterine and ovarian morphological responses | |
Elli et al. | Effect of a single dose of ibuprofen lysinate before embryo transfer on pregnancy rates in cows | |
KR20010093276A (ko) | 불임증 치료 | |
Kirby et al. | Response of dairy cows treated with bovine somatotropin to a luteolytic dose of prostaglandin F2α | |
KR20010093280A (ko) | 불임증 치료 | |
JP3881690B2 (ja) | 子宮血液潅流向上薬製造へのシクロオキシゲナーゼ阻害薬の使用 | |
JP5139294B2 (ja) | 妊娠促進剤 | |
JP2003520823A5 (ja) | ||
Abu-Musa et al. | Artificial endometrial preparation for oocyte donation using synthetic estrogen and progestogen | |
Rajamahendran et al. | Synchronization of estrus and ovulation in cattle | |
von Wolff et al. | Endometriosis—Case Discussion and IVF Treatments Suggested by Different Centres | |
Xia et al. | Treatment of Repeated Implantation Failures with Sequential Embryo Transfer to Achieve a Successful Pregnancy: A Case Report | |
RU2526203C1 (ru) | Метод получения антилютеальной крови - алк, способ лечения и профилактики послеродовых акушерско-гинекологических заболеваний у коров | |
Jamila et al. | Restoration of the Endometrium in Asherman's Syndrome Using Stem Cells | |
Shah et al. | Role of Luteal Phase Support in IUI | |
Wischnik et al. | Tocolytic therapies in development for preterm labour | |
Sterrenburg et al. | Drugs in reproductive medicine | |
Atkinson | Medical treatments in infertility | |
CA2362940A1 (en) | Treatment of infertility | |
De Decker et al. | Oestrogen supplementation in gamete intrafallopian transfer (GIFT)—a prospective randomised study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040402 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040517 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040712 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050405 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050628 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050815 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060215 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060403 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060522 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20061024 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20061113 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |